Acrylamide Alters CREB and Retinoic Acid Signalling Pathways During Differentiation of the Human Neuroblastoma SH-SY5Y Cell Line

Overview

Journal Sci Rep

Specialty Science

Date 2020 Oct 8

PMID 33028897

Citations 14

Authors

Kristina Attoff

Ylva Johansson

Andrea Cediel-Ulloa

Jessica Lundqvist

Rajinder Gupta

Florian Caiment

Anda Gliga

Anna Forsby

Affiliations

Soon will be listed here.

Abstract

Acrylamide (ACR) is a known neurotoxicant which crosses the blood-brain barrier, passes the placenta and has been detected in breast milk. Hence, early-life exposure to ACR could lead to developmental neurotoxicity. The aim of this study was to elucidate if non-cytotoxic concentrations of ACR alter neuronal differentiation by studying gene expression of markers significant for neurodevelopment in the human neuroblastoma SH-SY5Y cell model. Firstly, by using RNASeq we identified two relevant pathways that are activated during 9 days of retinoic acid (RA) induced differentiation i.e. RA receptor (RAR) activation and the cAMP response element-binding protein (CREB) signalling pathways. Next, by qPCR we showed that 1 and 70 µM ACR after 9 days exposure alter the expression of 13 out of 36 genes in the RAR activation pathway and 18 out of 47 in the CREB signalling pathway. Furthermore, the expression of established neuronal markers i.e. BDNF, STXBP2, STX3, TGFB1 and CHAT were down-regulated. Decreased protein expression of BDNF and altered ratio of phosphorylated CREB to total CREB were confirmed by western blot. Our results reveal that micromolar concentrations of ACR sustain proliferation, decrease neurite outgrowth and interfere with signalling pathways involved in neuronal differentiation in the SH-SY5Y cell model.

Citing Articles

Thiol-Based Redox Molecules: Potential Antidotes for Acrylamide Toxicity.

Martin V, Trus M, Atlas D Antioxidants (Basel). 2025; 13(12.

PMID: 39765760 PMC: 11672525. DOI: 10.3390/antiox13121431.

The transition state for coupled folding and binding of a disordered DNA binding domain resembles the unbound state.

Kuravsky M, Kelly C, Redfield C, Shammas S Nucleic Acids Res. 2024; 52(19):11822-11837.

PMID: 39315703 PMC: 11514473. DOI: 10.1093/nar/gkae794.

USP44 Overexpression Drives a MYC-Like Gene Expression Program in Neuroblastoma through Epigenetic Reprogramming.

Ekstrom T, Hussain S, Bedekovics T, Ali A, Paolini L, Mahmood H Mol Cancer Res. 2024; 22(9):812-825.

PMID: 38775808 PMC: 11372370. DOI: 10.1158/1541-7786.MCR-23-0454.

Stable knockdown of Drp1 improves retinoic acid-BDNF-induced neuronal differentiation through global transcriptomic changes and results in reduced phosphorylation of ERK1/2 independently of DUSP1 and 6.

Ghani M, Zohar P, Ujlaki G, Toth M, Amsalu H, Poliska S Front Cell Dev Biol. 2024; 12:1342741.

PMID: 38550381 PMC: 10972930. DOI: 10.3389/fcell.2024.1342741.

Effect of Acrylamide and Mycotoxins in SH-SY5Y Cells: A Review.

Bridgeman L, Juan C, Berrada H, Juan-Garcia A Toxins (Basel). 2024; 16(2).

PMID: 38393165 PMC: 10892127. DOI: 10.3390/toxins16020087.

References

Mottram D, Wedzicha B, Dodson A . Acrylamide is formed in the Maillard reaction. Nature. 2002; 419(6906):448-9. DOI: 10.1038/419448a. View

Kutting B, Schettgen T, Schwegler U, Fromme H, Uter W, Angerer J . Acrylamide as environmental noxious agent: a health risk assessment for the general population based on the internal acrylamide burden. Int J Hyg Environ Health. 2009; 212(5):470-80. DOI: 10.1016/j.ijheh.2009.01.002. View

Miller M, Carter D, Sipes I . Pharmacokinetics of acrylamide in Fisher-344 rats. Toxicol Appl Pharmacol. 1982; 63(1):36-44. DOI: 10.1016/0041-008x(82)90024-2. View

Sorgel F, Weissenbacher R, Kinzig-Schippers M, Hofmann A, Illauer M, Skott A . Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans. Chemotherapy. 2003; 48(6):267-74. DOI: 10.1159/000069715. View

Chapin R, Fail P, George J, Grizzle T, Heindel J, Harry G . The reproductive and neural toxicities of acrylamide and three analogues in Swiss mice, evaluated using the continuous breeding protocol. Fundam Appl Toxicol. 1995; 27(1):9-24. DOI: 10.1006/faat.1995.1104. View

Dearfield K, Douglas G, Ehling U, Moore M, Sega G, Brusick D . Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk. Mutat Res. 1995; 330(1-2):71-99. DOI: 10.1016/0027-5107(95)00037-j. View

Wise L, Gordon L, Soper K, Duchai D, Morrissey R . Developmental neurotoxicity evaluation of acrylamide in Sprague-Dawley rats. Neurotoxicol Teratol. 1995; 17(2):189-98. DOI: 10.1016/0892-0362(94)00071-k. View

Lai S, Gu Z, Zhao M, Li X, Ma Y, Luo L . Toxic effect of acrylamide on the development of hippocampal neurons of weaning rats. Neural Regen Res. 2017; 12(10):1648-1654. PMC: 5696846. DOI: 10.4103/1673-5374.217345. View

Attoff K, Gliga A, Lundqvist J, Norinder U, Forsby A . Whole genome microarray analysis of neural progenitor C17.2 cells during differentiation and validation of 30 neural mRNA biomarkers for estimation of developmental neurotoxicity. PLoS One. 2017; 12(12):e0190066. PMC: 5738075. DOI: 10.1371/journal.pone.0190066. View

10.

Chen J, Lee D, Chiu I . Cytotoxic effects of acrylamide in nerve growth factor or fibroblast growth factor 1-induced neurite outgrowth in PC12 cells. Arch Toxicol. 2013; 88(3):769-80. DOI: 10.1007/s00204-013-1174-6. View

11.

Barber D, Stevens S, LoPachin R . Proteomic analysis of rat striatal synaptosomes during acrylamide intoxication at a low dose rate. Toxicol Sci. 2007; 100(1):156-67. DOI: 10.1093/toxsci/kfm210. View

12.

Dobbing J . The development of the blood-brain barrier. Prog Brain Res. 1968; 29:417-27. DOI: 10.1016/S0079-6123(08)64172-2. View

13.

Grandjean P, Landrigan P . Developmental neurotoxicity of industrial chemicals. Lancet. 2006; 368(9553):2167-78. DOI: 10.1016/S0140-6736(06)69665-7. View

14.

Andersen H, Nielsen J, Grandjean P . Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology. 2000; 144(1-3):121-7. DOI: 10.1016/s0300-483x(99)00198-5. View

15.

Marks A, Harley K, Bradman A, Kogut K, Barr D, Johnson C . Organophosphate pesticide exposure and attention in young Mexican-American children: the CHAMACOS study. Environ Health Perspect. 2010; 118(12):1768-74. PMC: 3002198. DOI: 10.1289/ehp.1002056. View

16.

Gascon M, Vrijheid M, Martinez D, Forns J, Grimalt J, Torrent M . Effects of pre and postnatal exposure to low levels of polybromodiphenyl ethers on neurodevelopment and thyroid hormone levels at 4 years of age. Environ Int. 2011; 37(3):605-11. DOI: 10.1016/j.envint.2010.12.005. View

17.

Aschner M, Ceccatelli S, Daneshian M, Fritsche E, Hasiwa N, Hartung T . Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. ALTEX. 2016; 34(1):49-74. PMC: 5250586. DOI: 10.14573/altex.1604201. View

18.

Smirnova L, Hogberg H, Leist M, Hartung T . Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities. ALTEX. 2014; 31(2):129-56. PMC: 4778747. DOI: 10.14573/altex.1403271. View

19.

Yan X, Liu J, Ye Z, Huang J, He F, Xiao W . CaMKII-Mediated CREB Phosphorylation Is Involved in Ca2+-Induced BDNF mRNA Transcription and Neurite Outgrowth Promoted by Electrical Stimulation. PLoS One. 2016; 11(9):e0162784. PMC: 5017744. DOI: 10.1371/journal.pone.0162784. View

20.

Oates P, Touster O . In vitro fusion of Acanthamoeba phagolysosomes. III. Evidence that cyclic nucleotides and vacuole subpopulations respectively control the rate and the extent of vacuole fusion in Acanthamoeba homogenates. J Cell Biol. 1980; 85(3):804-10. PMC: 2111447. DOI: 10.1083/jcb.85.3.804. View